Cabasag, Leister John S.

HRN: 14-92-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2023
CEFTRIAXONE 1G (VIAL)
05/02/2023
05/08/2023
IV DRIP
2gms
Q24
T/c Dengue Fever With Warning Signs; Urti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: